| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |